NEW YORK (GenomeWeb News) – Cancer molecular diagnostics firm Epigenomics said on Thursday that it intends to launch a capital raise in January in order to fund current operations and increase its distribution capabilities.

The company intends to raise just under €5 million ($6.6 million), which would allow it to avoid having to offer a prospectus under German securities laws, it said. The planned financing would extend the cash runway of Epigenomics to at least the fourth quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.